Detection of molecular residual disease in stage II and III melanoma utilizing circulating tumor DNA.

被引：0
|
作者：
Chen, Emily
Brunsgaard, Elise Kornreich
Kuzel, Timothy
Tan, Alan
机构：
[1] Rush Univ, Rush Med Coll, Chicago, IL USA
[2] Rush Univ, Med Ctr, Chicago, IL USA
[3] Northwestern Univ, Chicago, IL USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21564
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma
    Kollipara, Revathi
    Budde, Griffin
    Aushev, Vasily N.
    Brunsgaard, Elise Kornreich
    Kuzel, Timothy
    O'Donoghue, Cristina
    Riddell, Timothy
    Palsuledesai, Charuta C.
    Krainock, Michael
    Liu, Minetta C.
    Tan, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Circulating Tumor DNA in Stage II and III Melanoma
    Brunsgaard, Elise K.
    Bowles, Tawnya L.
    Asare, Elliot A.
    Grossmann, Kenneth
    Boucher, Kenneth M.
    Grossmann, Allie
    Jackson, Julie A.
    Wada, David A.
    Grandemange, Andrew
    Hyngstrom, John R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 392 - 393
  • [3] Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma
    Brunsgaard, Elise K.
    Bowles, Tawnya L.
    Asare, Elliot A.
    Grossmann, Kenneth
    Boucher, Kenneth M.
    Grossmann, Allie
    Jackson, Julie A.
    Wada, David A.
    Rathore, Richa
    Budde, Griffin
    Grandemange, Andrew
    Hyngstrom, John R.
    MELANOMA RESEARCH, 2023, 33 (03) : 184 - 191
  • [4] Development of a methylation-based, tissue-agnostic test for the detection of molecular residual disease by circulating tumor DNA.
    Shen, John Paul Y. C.
    Reiter, Johannes
    Babiarz, Joshua
    Srinivasan, Preethi
    Lu, Fei
    Haghshenas, Ehsan
    Chen, Tzu-Chun
    Liang, Nathan
    Joshi, Jayashree
    Huang, Hsiao-Yun
    Cerna, Liliana
    Alexander, Spenser
    Gutman, Boris
    Kushwaha, Garima
    Aushev, Vasily N.
    Cruz-Correa, Marcia
    Rabinowitz, Matthew
    Kawli, Trupti
    Aleshin, Alexey
    Cohen, Stacey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 266 - 266
  • [5] Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
    Mo, Shaobo
    Ye, Li
    Wang, Dongyang
    Han, Lingyu
    Zhou, Shuang
    Wang, Hui
    Dai, Weixing
    Wang, Yichao
    Luo, Wenqin
    Wang, Renjie
    Xu, Ye
    Cai, Sanjun
    Liu, Rui
    Wang, Zheng
    Cai, Guoxiang
    JAMA ONCOLOGY, 2023, 9 (06) : 770 - 778
  • [6] Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients
    Eroglu, Zeynep
    Krinshpun, Shifra
    Kalashnikova, Ekaterina
    Sudhaman, Sumedha
    Topcu, Turkan Ozturk
    Nichols, Matt
    Martin, Justin
    Bui, Katherine M.
    Palsuledesai, Charuta C.
    Malhotra, Meenakshi
    Olshan, Perry
    Markowitz, Joseph
    Khushalani, Nikhil I.
    Tarhini, Ahmad A.
    Messina, Jane L.
    Aleshin, Alexey
    CANCER, 2023, 129 (11) : 1723 - 1734
  • [7] Circulating Tumor DNA for Solid Tumor Minimal/ Molecular Residual Disease Detection in Cancer Survivors
    Sorscher, Steven
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (12): : 1168 - 1169
  • [8] Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I
    Chen, Kevin
    Usmani, Abul
    Chua, Chanelle
    Harris, Peter K.
    Binkley, Michael S.
    Azad, Tej D.
    Dudley, Jonathan C.
    Chaudhuri, Aadel A.
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (03) : 311 - 331
  • [9] Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Re-I Chin
    Kevin Chen
    Abul Usmani
    Chanelle Chua
    Peter K. Harris
    Michael S. Binkley
    Tej D. Azad
    Jonathan C. Dudley
    Aadel A. Chaudhuri
    Molecular Diagnosis & Therapy, 2019, 23 : 311 - 331
  • [10] Molecular residual disease detection with circulating tumor DNA analysis predicts relapse in patients with early stage breast cancer
    Turner, N.
    Garcia-Murillas, I.
    Chopra, N.
    Comino-Mendez, I.
    Beaney, M.
    Tovey, H.
    Cutts, R.
    Swift, C.
    Kriplani, D.
    Afentakis, M.
    Hrebien, S.
    Walsh, G.
    Johnston, S.
    Ring, A.
    Russell, S.
    Evans, A.
    Skene, A.
    Wheatley, D.
    Dowsett, M.
    Smith, I.
    CANCER RESEARCH, 2019, 79 (04)
12345